Literature DB >> 9525534

Residential setting as a risk factor for Lyme disease in a hyperendemic region.

E K Cromley1, M L Cartter, R D Mrozinski, S H Ertel.   

Abstract

The hypothesis that residence in a uniform medium-density residential development is associated with lower incidence of Lyme disease is tested with data from a rural, 12-town region of south-central Connecticut where the disease is hyperendemic. The residential setting for 424 cases identified by active surveillance from 1993 through 1995 was determined. Cases located within the Eastern Coastal ecologic region, where tick densities are known to be higher than inland and where most of the population in the region resides, were selected for further analysis. Within this region, residence in a homogeneous area of medium-density development at least 30 acres (12 ha) in size was associated with a two- to 10-fold lower level of risk than residence in surrounding less developed areas, depending on the estimate of residential population. Type of residential development may be an important factor to consider, in addition to other environmental variables, in studies of peridomestic vector-borne disease in human populations.

Entities:  

Mesh:

Year:  1998        PMID: 9525534     DOI: 10.1093/oxfordjournals.aje.a009473

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

Review 1.  Integrative literature review: a review of literature related to geographical information systems, healthcare access, and health outcomes.

Authors:  Barbara Ann Graves
Journal:  Perspect Health Inf Manag       Date:  2008-07-29

2.  An Examination of the Demographic and Environmental Variables Correlated with Lyme Disease Emergence in Virginia.

Authors:  Sara E Seukep; Korine N Kolivras; Yili Hong; Jie Li; Stephen P Prisley; James B Campbell; David N Gaines; Randel L Dymond
Journal:  Ecohealth       Date:  2015-07-11       Impact factor: 3.184

3.  Lyme disease risk influences human settlement in the wildland-urban interface: evidence from a longitudinal analysis of counties in the northeastern United States.

Authors:  Ashley E Larsen; Andrew J MacDonald; Andrew J Plantinga
Journal:  Am J Trop Med Hyg       Date:  2014-07-21       Impact factor: 2.345

Review 4.  Spatial dynamics of lyme disease: a review.

Authors:  Mary E Killilea; Andrea Swei; Robert S Lane; Cheryl J Briggs; Richard S Ostfeld
Journal:  Ecohealth       Date:  2008-06-05       Impact factor: 3.184

5.  Critical Evaluation of the Linkage Between Tick-Based Risk Measures and the Occurrence of Lyme Disease Cases.

Authors:  Lars Eisen; Rebecca J Eisen
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

6.  Diversity and distribution of tick species (Acari: Ixodidae) associated with human otoacariasis and socio-ecological risk factors of tick infestations in Sri Lanka.

Authors:  S Ariyarathne; D A Apanaskevich; P H Amarasinghe; R S Rajakaruna
Journal:  Exp Appl Acarol       Date:  2016-07-06       Impact factor: 2.132

7.  Evolution of northeastern and midwestern Borrelia burgdorferi, United States.

Authors:  Dustin Brisson; Mary F Vandermause; Jennifer K Meece; Kurt D Reed; Daniel E Dykhuizen
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

8.  Mapping Lyme disease incidence for diagnostic and preventive decisions, Maryland.

Authors:  Christina Frank; Alan D Fix; César A Peña; G Thomas Strickland
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

9.  Predicting spatiotemporal patterns of Lyme disease incidence from passively collected surveillance data for Borrelia burgdorferi sensu lato-infected Ixodes scapularis ticks.

Authors:  Eliza A H Little; John F Anderson; Kirby C Stafford; Lars Eisen; Rebecca J Eisen; Goudarz Molaei
Journal:  Ticks Tick Borne Dis       Date:  2019-04-18       Impact factor: 3.744

10.  Social-ecological factors determine spatial variation in human incidence of tick-borne ehrlichiosis.

Authors:  B R Bayles; B F Allan
Journal:  Epidemiol Infect       Date:  2013-11-26       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.